Suppressive effects of vascular endothelial growth factor-B on tumor growth in a mouse model of pancreatic neuroendocrine tumorigenesis.
<h4>Background</h4>The family of vascular endothelial growth factors (VEGF) contains key regulators of blood and lymph vessel development, including VEGF-A, -B, -C, -D, and placental growth factor. The role of VEGF-B during physiological or pathological angiogenesis has not yet been conc...
Guardado en:
Autores principales: | Imke Albrecht, Lucie Kopfstein, Karin Strittmatter, Tibor Schomber, Annelie Falkevall, Carolina E Hagberg, Pascal Lorentz, Michael Jeltsch, Kari Alitalo, Ulf Eriksson, Gerhard Christofori, Kristian Pietras |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fa5b3c2c3fb94973ad79dd3b3be2ade1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
AAS, growth hormone, and insulin abuse: psychological and neuroendocrine effects
por: Michael R Graham, et al.
Publicado: (2008) -
A miR-375/YAP axis regulates neuroendocrine differentiation and tumorigenesis in lung carcinoid cells
por: Xiaojing Yang, et al.
Publicado: (2021) -
The somatostatin analogue octreotide inhibits growth of small intestine neuroendocrine tumour cells.
por: Su-Chen Li, et al.
Publicado: (2012) -
Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1
por: Sawan Kumar Jha, et al.
Publicado: (2017) -
Growth hormone regulates neuroendocrine responses to weight loss via AgRP neurons
por: Isadora C. Furigo, et al.
Publicado: (2019)